NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Getty Images Soars, Then Sinks, After AI Licensing Deal with Perplexity

Getty Images’ stock spiked up to 85% after signing a multiyear licensing deal with AI search startup Perplexity — but early excitement quickly faded as shares plunged back down.

Getty Images Soars, Then Sinks, After AI Licensing Deal with Perplexity
Credit: Getty Images
Already have an account? Sign in.
10/31/2025 · 12:42 PM
GETY
/ Don’t stop at just one post.

Related↓

Getty Images Strikes Multi-Year Deal to Bring Licensed Photos into ChatGPT
06/22/2026 · 5:57 AM

Getty Images Strikes Multi-Year Deal to Bring Licensed Photos into ChatGPT

Getty Images signed a deal with OpenAI to show its licensed photos and videos in ChatGPT search results.

/ Subscriber only
/ Read more

Feed↓

Nancy Pelosi Discloses Up to $6 Million in Bullish Intel and Uber Call Options
06/24/2026 · 12:33 PM

Nancy Pelosi Discloses Up to $6 Million in Bullish Intel and Uber Call Options

Her first major trades since early 2026.

/ Subscriber only
Raymond James Highlights Viking’s New Amylin-Based Weight Loss Drug VK3019 Entering Clinic
Featured/ 06/24/2026 · 11:47 AM

Raymond James Highlights Viking’s New Amylin-Based Weight Loss Drug VK3019 Entering Clinic

Viking Therapeutics advances its obesity portfolio with the start of a Phase 1 trial for VK3019, a novel dual amylin and calcitonin receptor agonist. Analyst sees major potential.

/ Subscriber only
Cantor Fitzgerald Initiates Overweight Coverage on Silence Therapeutics (SLN), Calls Stock “Materially Undervalued”
Featured/ 06/24/2026 · 10:39 AM

Cantor Fitzgerald Initiates Overweight Coverage on Silence Therapeutics, Calls Stock “Materially Undervalued”

The firm initiated Overweight coverage citing strong divesiran Phase 2 potential and 160%+ upside.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe